Article at a Glance: Lichen Planus
- Medical Definition: A chronic, T-cell mediated autoimmune inflammatory disorder attacking the skin, oral mucosa, scalp, and nails.
- Hallmark Symptoms: Itchy, flat-topped violaceous (purple) bumps on the skin, and painless lacy white lines or painful red erosions in the mouth.
- Dietary Restrictions: Spicy, highly acidic, and mechanically rough (crunchy) foods must be completely avoided to prevent severe oral pain and delayed healing.
- 2026 Treatment Updates: Janus Kinase (JAK) inhibitors (such as upadacitinib) are providing rapid remission for treatment-resistant cases globally.
- Contagion Risk: Zero. It is an internal immune system error, not an infectious disease.
Lichen planus is a complex, chronic inflammatory condition requiring precise clinical diagnosis and a highly tailored therapeutic approach. While the exact etiology remains idiopathic, modern immunology confirms that it is driven by an overactive immune system. Specifically, cytotoxic CD8+ T-cell lymphocytes mistakenly identify basal keratinocytes—the cells forming the foundation of the skin and mucous membranes—as foreign threats and destroy them [1].
This comprehensive clinical guide outlines the pathophysiology, causes, distinct anatomical subtypes, diagnostic criteria, and detailed standard therapies—including precise dosing structures—available for patients globally.
Common Triggers and Associated Causes
While the foundational cause is an autoimmune malfunction driven by the IFN-γ/CXCL10 axis, specific environmental factors and systemic conditions directly trigger the onset or drastically exacerbate existing flares:
- Hepatitis C Virus (HCV): Large-scale epidemiological data demonstrates a statistically significant link between chronic Hepatitis C infection and the onset of lichen planus, particularly the erosive oral variant [2].
- Lichenoid Drug Eruptions: Prescription medications—including beta-blockers, ACE inhibitors, antimalarials, and NSAIDs—can induce skin eruptions mimicking lichen planus. These resolve weeks to months after the offending drug is discontinued.
- Dental Materials: Allergic contact hypersensitivity to restorative dental amalgam or gold triggers localized oral lichen planus (OLP) adjacent to the fillings.
- Viral Infections and Stress: Immune hyperactivation following severe viral illnesses or periods of profound psychological stress triggers elevated systemic cortisol and inflammatory cytokines, acting as a direct catalyst for acute cutaneous flares.
Classification: Clinical Types of Lichen Planus
Lichen planus is highly variable. Accurate categorization is critical for selecting the right treatment modality, as mucosal involvement requires fundamentally different medications than scalp involvement.
| Type / Location | Primary Clinical Presentation |
|---|---|
| Cutaneous (Skin) | Intensely itchy, flat-topped, violaceous (purple) papules. Characterized by Wickham striae—fine, lacy white lines on the surface. |
| Oral & Mucosal | Presents as painless lacy white patches or intensely painful, swollen, red open sores (erosions). |
| Lichen Planopilaris | Inflammation and scaling around hair follicles leading to irreversible scarring and permanent hair loss. |
| Nail Lichen Planus | Causes progressive nail thinning, longitudinal ridging, splitting (onychorrhexis), and potentially complete nail destruction. |
Detailed Breakdown of Subtypes
Cutaneous Lichen Planus (Skin)
The most common presentation. Typically manifests on the flexor surfaces of the wrists, forearms, lower legs, and lower back. It follows the “6 Ps”: planar (flat-topped), purple (violaceous), polygonal, pruritic (itchy), papules, and plaques. Most cases resolve spontaneously within 1 to 2 years but leave behind stubborn post-inflammatory hyperpigmentation.
Oral Lichen Planus (OLP)
A chronic, relapsing condition affecting the inner cheeks (buccal mucosa), gums (desquamative gingivitis), and tongue. It is subdivided into six morphological types:
- Reticular: The most common; presents as asymptomatic, spiderweb-like white lines (Wickham striae).
- Erosive & Atrophic: Highly symptomatic. The protective mucosa thins out or forms open, red, painful ulcers that make eating and speaking difficult.
- Plaque-like, Papular, Bullous: Less common variants presenting as thick white patches, small bumps, or fluid-filled blisters in the mouth.
Lichen Planopilaris (Scalp)
A variant that aggressively attacks the hair follicle. It presents with perifollicular erythema (redness around the hair shaft) and hyperkeratosis (scaling). It causes scarring (cicatricial) alopecia. Once the follicle scars over, hair loss is completely irreversible. Frontal fibrosing alopecia (FFA) is considered a specific subset of this condition affecting the hairline and eyebrows in postmenopausal women.
Hypertrophic Lichen Planus
Presents as extremely thick, warty, intensely itchy plaques, most frequently found on the anterior shins and ankles. Due to the thickness of the plaques, topical creams often fail to penetrate, requiring intralesional injections.
Lichen Planus Pigmentosus (LPPigm)
This variant is exceptionally common today, particularly in patients with Fitzpatrick skin types IV to VI (South Asian populations). Unlike classic cutaneous LP, Lichen Planus Pigmentosus does not typically present with itchy purple bumps. Instead, it appears as flat, diffuse, or reticulated gray-brown or dark-brown patches.
- Location: Primarily affects sun-exposed areas (face, neck, forehead) and flexural folds (underarms, groin).
- Common Triggers: Heavy exposure to UV radiation (sunlight), application of mustard oil, amla oil, henna (mehndi), and commercial hair dyes containing PPD (paraphenylenediamine).
- Diagnostic Features: Dermoscopy reveals prominent pigmentary incontinence, where destroyed basal cells drop melanin deep into the dermis, where it is consumed by melanophages. Because the pigment is trapped deep in the skin, it is highly resistant to standard skin-lightening creams.
Foods to Avoid: Dietary Management for Oral Lichen Planus
For mucosal variants, dietary regulation is a mandatory component of pain management. Physical or chemical trauma triggers the Koebner phenomenon, where new inflammatory lesions form at the exact site of oral irritation.
- Spicy and Hot Foods: Capsaicin (chili peppers, curries) acts as a severe chemical irritant to compromised mucosa.
- Highly Acidic Foods: Citrus fruits (lemons, oranges), tomatoes, pineapple, and vinegar burn open erosions.
- Crunchy, Hard Textures: Crusty breads, potato chips, and hard taco shells cause micro-tears on the gums and cheeks.
- Specific Flavorings (Mint & Cinnamon): Switch immediately to a mild, unflavored, sodium lauryl sulfate (SLS)-free toothpaste to avoid cinnamaldehyde hypersensitivity.
- Thermal Trauma: Consume all meals and beverages at lukewarm or room temperature to prevent thermal injury.
Diagnostic Workup & Essential Blood Tests
Clinical examination is supported by precise laboratory testing. Before initiating systemic oral steroids or immunosuppressants, dermatologists require comprehensive baseline blood work to monitor for organ toxicity and rule out underlying infections.
Initial Pre-Treatment Blood Panel
- Complete Blood Count (CBC): Identifies baseline anemia or existing bone marrow suppression.
- Liver Function Tests (LFTs) & Renal Function Tests (RFTs / Serum Creatinine): Mandatory before starting Methotrexate or Cyclosporine to ensure the liver and kidneys can clear the drugs safely.
- Fasting Blood Glucose & HbA1c: Required before oral steroids (Prednisone), which can cause sudden spikes in blood sugar and induce steroid-diabetes.
- Hepatitis B (HBsAg) & Hepatitis C (Anti-HCV) Serology: Chronic viral infections can trigger LP or be lethally reactivated by immunosuppressants.
- Mantoux Test / IGRA (TB Screening): Essential in endemic regions to rule out latent tuberculosis before suppressing the immune system.
- Lipid Profile & Thyroid Panel: Systemic retinoids and steroids can elevate triglycerides and alter metabolic function.
Routine Monitoring (While on Oral Medication)
Patients on systemic therapies require a CBC, LFT, and RFT drawn every 2 to 4 weeks during the initial treatment phase. Once blood levels are stable, monitoring is spaced out to every 2 to 3 months.
Comprehensive Treatment Protocols by Subtype
Treatment is strictly tailored to the anatomical location and morphological subtype of the disease.
Topical Therapies (For Localized Cutaneous & Mild Oral LP)
Topical Corticosteroids (e.g., Clobetasol Propionate 0.05%)
- Role: First-line defense. High-potency anti-inflammatory agents suppress localized T-cell activity.
- Usage & Dosing: Applied 1-2 times daily for 2 to 4 weeks. Must be tapered (e.g., every other day) to prevent rebound flares.
- Side Effects: Skin thinning (atrophy), stretch marks, hypopigmentation, and oral thrush if used intraorally.
- Pediatric & Pregnancy: Lower potency required for children (e.g., Hydrocortisone). FDA Category C for pregnancy (use localized, short-term).
Topical Calcineurin Inhibitors (Tacrolimus 0.1%, Pimecrolimus 1%)
- Role: Steroid-sparing immunomodulators. Highly effective for facial, genital, and oral lesions because they do not cause skin thinning. A primary topical for treating Lichen Planus Pigmentosus on the face.
- Usage: Can be used for longer maintenance periods. Commonly causes intense, temporary burning upon initial applications.
- Pediatric Dosing: Approved for children >2 years using the 0.03% Tacrolimus formulation.
Intralesional (IL) Steroid Injections (For Hypertrophic & Scalp/Nail LP)
Triamcinolone Acetonide (Kenalog) IL Injections
- Role: Delivers high-concentration steroids directly into the dermis, bypassing the skin barrier. Crucial for Hypertrophic LP (thick leg plaques) where creams cannot penetrate, and Lichen Planopilaris to rapidly halt follicular destruction. Also injected into the nail matrix for nail LP.
- Dosing: Formulated between 2.5 mg/mL to 10 mg/mL depending on the site. Scalp/face injections use lower concentrations (2.5-5 mg/mL), while thick leg plaques require 10 mg/mL. Max volume is typically kept under 20-30 mg per session to prevent systemic adrenal suppression.
- Frequency: Administered every 3 to 4 weeks by a dermatologist.
- Side Effects: Localized fat atrophy (leaving a small dent in the skin), hypopigmentation (lightening of the skin), and pain at the injection site.
Systemic Oral Immunosuppressants (For Severe, Erosive, & Refractory OLP)
Hydroxychloroquine (HCQS)
- Role: An antimalarial drug highly utilized for treating Lichen Planopilaris (scalp) and severe Lichen Planus Pigmentosus. It mitigates antigen presentation to T-cells.
- Standard Dosing: 200 mg taken once or twice daily (typically dosed at 5 to 6.5 mg/kg of ideal body weight). Maximum dose is 400 mg/day.
- Precautions: Requires a baseline ophthalmology exam (fundus/OCT) and annual check-ups to monitor for retinal toxicity (maculopathy). Screening for G6PD deficiency is advised in susceptible populations.
Methotrexate
- Role: Long-term, steroid-sparing agent that inhibits DNA synthesis in immune cells. Used for chronic conditions like severe erosive oral lichen planus and widespread cutaneous LP.
- Standard Dosing:
– Adults: 10 to 15 mg taken once weekly (not daily).
– Pediatrics: 0.2 to 0.4 mg/kg/week.
Must be co-administered with Folic Acid (1-5 mg daily, skipping the day of methotrexate) to reduce toxicities. - Side Effects: Nausea, oral ulcers, hepatotoxicity (liver damage), bone marrow suppression. Requires frequent blood monitoring.
- Pregnancy Warning: ABSOLUTE CONTRAINDICATION (Category X). Causes severe birth defects. Strict contraception required.
Mycophenolate Mofetil (MMF)
- Role: Specifically targets T-cell and B-cell proliferation. Highly favored as a second-line treatment for severe, refractory erosive oral lichen planus when methotrexate fails.
- Standard Dosing:
– Adults: 1 to 2 grams per day, divided into two doses.
– Pediatrics: 600 mg/m² body surface area twice daily. - Side Effects: Significant gastrointestinal upset (diarrhea, cramping), increased risk of viral infections.
- Pregnancy Warning: Category X. Highly teratogenic.
Cyclosporine
- Role: A very fast-acting calcineurin inhibitor used as a “rescue therapy” to quickly gain control of explosive, rapidly progressing erosive lichen planus.
- Standard Dosing: 3 to 5 mg/kg/day divided into two doses.
- Duration & Stopping: Due to severe toxicities, it is typically used for a maximum of 3 to 6 months to bridge the patient to a safer long-term drug like Methotrexate.
- Side Effects: Nephrotoxicity (kidney damage), severe hypertension (high blood pressure), gum overgrowth (gingival hyperplasia).
What is New in 2026? The JAK Inhibitor Revolution
Oral JAK Inhibitors (Upadacitinib, Baricitinib)
- Role: The newest breakthrough in dermatology. These drugs actively block the IFN-γ and JAK-STAT cellular pathways driving the disease, successfully clearing treatment-resistant lichen planus within weeks [5].
- Usage: Taken daily. Rapidly reduces pruritus (itching) within 10-14 days.
- Precautions: Carries black-box warnings for serious cardiovascular events and blood clots. Avoided during pregnancy.
Relapse Rates: Why Does Lichen Planus Come Back?
Understanding the disease lifecycle prevents frustration. Cutaneous (skin) lichen planus is generally self-limiting. Most cases clear spontaneously within 12 to 24 months, with a relapse rate of only 15% to 20% [1].
Conversely, Oral Lichen Planus (OLP) is a chronic condition. Clinical analyses show over 50% of patients experience an oral relapse within 4 to 17 weeks of discontinuing topical corticosteroid treatments [3]. Relapses occur due to:
- Immunological Memory: Dormant memory T-cells remain in the healed mucosa, reactivating upon encountering a trigger.
- Premature Tapering: Stopping prescription steroids abruptly rather than tapering down allows a violent inflammatory rebound.
- Persistent Triggers: Unmanaged stress (cortisol), poor sleep, or continuous mechanical trauma to the gums guarantees a relapse.
Prevention: Maintain gentle oral hygiene, practice daily stress reduction, and always complete medication tapers strictly as prescribed.
Frequently Asked Questions (Patient FAQ)
Will my lichen planus ever go away completely?
If it is on your skin, there is a very high chance (over 80%) that it will clear up completely within 1 to 2 years. However, if it affects your mouth, genitals, or scalp, it is considered chronic. We can achieve deep remission so you are pain-free, but it may periodically flare up throughout your life.
Why does my mouth hurt so much when I eat spicy food?
The disease strips away the protective top layer of your oral lining, leaving raw erosions. Spices (capsaicin) and acids (citrus, tomatoes) act as direct chemical burns on unprotected nerve endings.
Can I pass this to my partner or my children?
No. Lichen planus is an internal autoimmune error. It is 100% physically impossible to transmit it via touch, kissing, sharing utensils, or sexual contact.
Why did my doctor ask to test me for Hepatitis C?
Extensive clinical research shows a strong link between the Hepatitis C virus and the onset of lichen planus. We test for it to ensure there isn’t an underlying viral infection triggering your immune system.
Why is my face getting dark patches without any itching?
This is highly likely Lichen Planus Pigmentosus (LPPigm). Unlike the classic skin variant, this type presents as flat, dark gray or brown patches on sun-exposed areas like the face and neck. It is frequently triggered by UV exposure, hair dyes, or applying mustard oil to the scalp.
My hair is falling out from lichen planopilaris—will it grow back?
Unfortunately, no. Lichen planopilaris causes scarring (cicatricial) alopecia. The hair follicle is destroyed and replaced by scar tissue. Immediate intralesional injections or systemic therapy (like HCQS) is essential to stop the inflammation and save your remaining hair.
Does having this mean I will get skin cancer?
Skin lichen planus does not cause cancer. However, the long-term erosive form of oral or genital lichen planus carries a small risk (1% to 3%) of developing into squamous cell carcinoma over many years. Regular biannual dermatological check-ups are mandatory.
Can stress actually make my skin break out in lichen planus?
Yes. Severe psychological stress floods the body with cortisol and inflammatory cytokines. This chemical storm wakes up dormant T-cells and causes massive flare-ups.
How frequently do I need blood tests while on medication?
If you are taking systemic medications like Methotrexate or Cyclosporine, your dermatologist will require a Complete Blood Count (CBC) and liver/kidney function tests every 2 to 4 weeks initially. Once your levels stabilize, tests are spaced out to every 2 to 3 months.
Can I stop applying the steroid cream once the itching stops?
No. Stopping topical or oral steroids abruptly causes a “rebound flare,” where the inflammation returns much worse than before. You must taper the dosage down slowly according to your dermatologist’s exact instructions.
Expert Lichen Planus Treatment in Kathmandu
Don’t let chronic itching, permanent hair loss, or severe oral pain dictate your quality of life. Achieving deep remission from Lichen Planus requires precise diagnostics and a modern pharmacological approach tailored specifically to your subtype.
Why Choose Derma Clinic?
- Specialized Expertise: Led by Dr. Utsav Sharma, possessing over 15 years of focused experience in complex, immune-mediated dermatoses.
- Global Standard Therapies: We offer advanced standard approved and available treatments in Nepal in the best possible way.
- Holistic Monitoring: Complete laboratory screening and long-term remission management tailored to the latest clinical guidelines.
Take control of your skin health today.
📍 Location: Derma Clinic PVT LTD, 4th Floor Bishal Bhawan, Basundhara Chowki, Near Basundhara Chowki Petrol Pump, Kathmandu 44600, Nepal
Clinical References & External Resources
- StatPearls [Internet]. “Lichen Planus – Epidemiology, Genetics, and Pathogenesis.” National Center for Biotechnology Information (NCBI). View on PubMed/NCBI.
- Mayo Clinic. “Lichen planus – Symptoms, Diagnosis, and treatment.” View Resource.
- Wutticharoenwong, V., et al. “Factors involved in the remission of oral lichen planus treated with topical corticosteroids.” PMC11078943. View Clinical Trial on PMC.
- American Academy of Dermatology (AAD). “Lichen planus: Diagnosis and treatment guidelines.” View AAD Guidelines.
- Pindado-Ortega, C., et al. “Successful Treatment of Lichen Planus With Oral Upadacitinib.” Journal of Drugs in Dermatology. 2023.
- Gorouhi, F., et al. “Medical and Surgical Treatment of Lichen Planus.” American Journal of Clinical Dermatology, vol. 15, 2014, pp. 351–373.
- FDA Drug Safety Communication: Mycophenolate mofetil (CellCept) and Mycophenolic acid (Myfortic) risk of miscarriage and birth defects. View FDA Safety Info.